Meanwhile, β-blockers, anticonvulsants, 5-HT2 antagonists, tricyclic antidepressants, and calcium antagonists are commonly prescribed as migraine prophylaxes that are daily administered to reduce the frequency and severity of migraine and enhance patients' therapeutic responses to the acute treatments [5, 6]. This evidence concerns the gene HTR2A and migraine disorder.